🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioNTech SE

BNTX Healthcare
$91.18 +$1.76 (1.97%)
Market Cap: $21.88 B
Gurus Holding
3
Popularity Rank
#2896
% of Shares Held
0.00%
Net Activity (Q4 2025)
+$988,556

Guru Ownership Trend

Guru Analysis for BioNTech SE (BNTX)

BioNTech SE (BNTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $946,813.12.

Top institutional holders include Ray Dalio and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $988,556 net inflow during the quarter.

Recent activity highlights Ray Dalio who opened a new position.

Key Holders

Top 5 by Value

$469,050
$281,506
$238,000

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$988,556
Total Buy Value
New Buys 3
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
3

FAQs for BioNTech SE (BNTX)

Major holders include Ray Dalio ($469,050), Paul Tudor Jones ($281,506), Jefferies Group ($238,000). According to the latest reported data, 3 tracked investment managers collectively hold approximately 10,384 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $988,556, with 3 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in BNTX during the most recent reporting period.

Yes, 3 managers opened new positions in BNTX, and 0 increased their existing holdings. The total reported buy value was $988,556.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 4,927 $469,050 Q4 2025
0.00% New Buy 2,957 $281,506 Q4 2025
0.00% New Buy 2,500 $238,000 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form